This is the session PRR will be in as per the agenda
Wednesday, January 11, 2012
9:00 - 10:30 AM Hematology & Immunology Analyst: Stephen Dunn, LifeTech Capital
-- Dendreon, David L. Urdal, Executive VP, CSO
-- Prima BioMed, Martin Rogers, CEO
-- ImmunoCellular, Manish Singh, CEO
-- Coronado, Bobby Sandage, CEO
-- bluebird bio, Jeffrey Walsh, COO
-- NexImmune, Ken Carter, CEO
-- Maxcyte, Doug Doerfler, CEO
prr to present@ alliance for regenerative med, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.010(3.51%) |
Mkt cap ! $400.0M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.0¢ | $1.034M | 3.758M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 98156 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 85523 | 9 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |